[1] Watkins DA, Johnson CO, Colquhoun SM,et al. Global,
Regional, and National Burden of Rheumatic Heart Dis-ease, 1990-2015 [J]. N Engl J Med, 2017,377(8):713-722.
[2] Munro HM, Tarone RE, Wang TJ,et al. Menthol and
Nonmenthol Cigarette Smoking: All- Cause Deaths, Car-diovascular Disease Deaths, and Other Causes of Death
Among Blacks and Whites [J]. Circulation,2016,133(19):
1861-1866.
[3] Ray KK, Landmesser U, Leiter LA,et al. Inclisiran in
Patients at High Cardiovascular Risk with Elevated LDL
Cholesterol [J]. N Engl J Med,2017,376(15):1430-1440.
[4] Williamson JD, Supiano MA, Applegate WB,et al. In-tensive vs Standard Blood Pressure Control and Cardiovas-cular Disease Outcomes in Adults Aged ≥75 Years: A
Randomized Clinical Trial [J]. JAMA,2016,315(24):2673-2682.
[5] Mente A, O'Donnell M, Rangarajan S,et al. Associations
of urinary sodium excretion with cardiovascular events in
individuals with and without hypertension: a pooled analy-sis of data from four studies [J]. The Lancet, 2016,388
(10043):465-475.
[6] Khera AV, Emdin CA, Drake I,et al. Genetic Risk, Ad-herence to a Healthy Lifestyle, and Coronary Disease [J].
N Engl J Med,2016,375(24):2349-2358.
[7] Wang C, Zhao P, Luo P,et al. Prevalence and risk fac-tors of coronary artery disease in patients with chronic vi-ral hepatitis [J]. Postgraduate Medicine, 2015,127(8):786-790.
[8] Sorlie PD, Nieto FJ, Adam E,et al. A prospective study
of cytomegalovirus, herpes simplex virus 1, and coronary
heart disease: the atherosclerosis risk in communities (AR-IC) study [J]. Arch Intern Med, 2000,160(13):2027-2032.
[9] Lin YJ, Gutierrez J, Albuquerque ALA,et al. HIV infec-tion as vascular risk: A systematic review of the literature
and meta-analysis [J]. PLoS One, 2017,12(5):e0176686.
[10] Momiyama Y, Ohmori R, Taniguchi H,et al. Associa-tion of Mycoplasma pneumoniae infection with coronary ar-tery disease and its interaction with chlamydial infection
[J]. Atherosclerosis, 2004,176(1):139-144.
[11] 王贵强,王福生,成军,等.慢性乙型肝炎防治指南(2015更新版)
[J].临床肝胆病杂志,2015,31(12):1941-1960.
[12] Li JJ, Li YS, Fang CH, et al. Effects of simvastatin
within two weeks on anti-inflammatory cytokine interleu-kin 10 in patients with unstable angina [J]. Heart, 2006,92
(4):529-530.
[13] 马玉龙,李晓梅,杨毅宁,等.乙型肝炎病毒感染与冠心病的关联
性分析[J].中国动脉硬化杂志,2014,22(10):1035-1038.
[14] Kuo CS, Chen YT, Hsu CY,et al. The impact of chron-ic hepatitis B infection on major adverse cardiovascular
events and all-cause mortality in patients with diabetes: a
nationwide population-based study from Taiwan [J]. BMJOpen,2017,7(8):e016179.
[15] Aiolfi R, Sitia G. Chronic hepatitis B: role of anti-platelet
therapy in inflammation control [J]. Cell Mol Immunol,
2015,12(3):264-268.
[16] Hao S, Wang Y, Gao G,et al. Hepatitis B Virus Upreg-ulates the Expression of C-reactive Protein Both in vivo
and in vitro [J]. Annals of Clinical & Laboratory Science,
2017,47(4):432-435.
[17] Trehanpati N, Vyas AK. Immune Regulation by T Regu-latory Cells in Hepatitis B Virus- Related Inflammation
and Cancer [J]. Scand J Immunol, 2017,85(3):175-181.
[18] Li WC, Lee YY, Chen IC, et al. Association between
the hepatitis B and C viruses and metabolic diseases in pa-tients stratified by age [J]. Liver Int, 2013,33(8):1194-1202.
[19] 吴正浩,陈捷.人巨细胞病毒感染对老年冠心病患者冠状动脉病
变程度及Ghrelin/Obestatin的影响[J].山东医药,2016,56(44):
46-47.
[20] 杜立平,朱淑芬.冠心病患者动脉粥样硬化与人巨细胞病毒检测
结果的相关性分析[J].标记免疫分析与临床,2016,23(12):1379-1381.
[21] 刘大男,李金生,刘兴德,等.巨细胞病毒感染与冠心病急性心肌
梗死的相关性研究[J].中国老年学杂志,2009,2(29):203-205.
[22] 韩卫红,李国良,王淑霞. HCMV感染与动脉粥样硬化及急性冠
脉综合征的相关性研究进展[J].河北医药,2011,33(13):2027-2029.
[23] Huang ZR, Yu LP, Yang XC,et al. Human cytomegalo-virus linked to stroke in a Chinese population [J]. CNS
Neurosci Ther,2012,18(6):457-460.
[24] 姚磊,晏玲,罗福康,等.冠心病患者外周血单个核细胞HCMV-DNA的荧光定量PCR检测[J].中国病原生物学杂志,2011,6(8):
571-573.
[25] 潘思争,叶秀玲,王玉城.单纯疱疹病毒感染与冠心病的关系探讨
[J].国际医药卫生导报,2005,11(24):83-84.
[26] Al-Ghamdi A. Role of herpes simplex virus-1, cytomega-lovirus and Epstein-Barr virus in atherosclerosis [J]. Pak J
Pharm Sci,2012,25(1):89-97.
[27] Zhu J, Nieto FJ, Horne BD, et al. Prospective study of
pathogen burden and risk of myocardial infarction or death
[J]. Circulation, 2001,103(1):45-51.
[28] Raza-Ahmad AKG, Murphy DA, Sullivan JA,et al. Evi-dence of type 2 herpes simplex infection in human coro-nary arteries at the time of coronary artery bypass surgery
[J]. Can J Cardiol, 1995,11(11):1025-1029.
[29] Rupprecht HJ, Blankenberg S, Bickel C,et al. Impact of
Viral and Bacterial Infectious Burden on Long-Term Prog-nosis in Patients With Coronary Artery Disease [J]. Circu-lation, 2001,104(1):25-31.
[30] Deeks SG, Lewin SR, Havlir DV. The end of AIDS:
HIV infection as a chronic disease [J]. The Lancet,2013,
382(9903):1525-1533.
[31] Zerbato JM, Serrao E, Lenzi G,et al. Establishment and
Reversal of HIV-1 Latency in Naive and Central Memory
CD4
+
T Cells In Vitro [J]. J Virol, 2016,90(18):8059-8073.
[32] Ballocca F, D'Ascenzo F, Gili S, et al. Cardiovascular
disease in patients with HIV [J]. Europe PMC, 2017,27(8):
558-563.
[33] Baekken M, Os I, Sandvik L,et al. Hypertension in an
urban HIV-positive population compared with the general
population: influence of combination antiretroviral therapy
[J]. J Hypertens, 2008,26(11):2126-2133.
[34] Lang S, Mary-Krause M, Simon A,et al. HIV replica-tion and immune status are independent predictors of the
risk of myocardial infarction in HIV- infected individuals
[J]. Clin Infect Dis, 2012,55(4):600-607.
[35] Lang S, Marykrause M, Cotte L,et al. Increased risk of
myocardial infarction in HIV- infected patients in France,
relative to the general population [J]. AIDS, 2010,24(8):
1228-1230.
[36] Choi AI, Li Y, Deeks SG, et al. Association between
kidney function and albuminuria with cardiovascular events
in HIV-infected persons [J]. Circulation, 2010,121(5):651-658.
[37] Narita M. Classification of Extrapulmonary Manifestations
Due to Mycoplasma pneumoniae Infection on the Basis of
Possible Pathogenesis [J]. Front Microbiol,2016,7:23.
[38] Bayram A, Erdo?an MB, Ek?i F, et al. Demonstration of
Chlamydophila pneumoniae, Mycoplasma pneumoniae, Cy-tomegalovirus, and Epstein- Barr virus in atherosclerotic
coronary arteries, nonrheumatic calcific aortic and rheumat-ic stenotic mitral valves by polymerase chain reaction [J].
Anadolu Kardiyol Derg,2011,11(3):237-243.
[39] Mizutani H. Immunologic responses in patients with Myco-plasma pneumoniae infections [J]. Am Rev Respir Dis,
1983,127(2):175-179.
[40] Higuchi ML, Sambiase N, Palomino S,et al. Detection
of Mycoplasma pneumoniae and Chlamydia pneumoniae in
ruptured atherosclerotic plaques [J]. Braz J Med Biol Res,
2000,33(9):1023-1026.
[41] Roggério A, Sambiase NV, Palomino SA, et al. Correla-tion of bacterial coinfection versus matrix metalloproteinase
9 and tissue inhibitor of metalloproteinase 1 expression in
aortic aneurysm and atherosclerosis [J]. Ann Vasc Surg,
2013,27(7):964-971.
[42] 白雪飞,周莹.肺炎支原体感染与冠心病的相关性分析[J].河南医
学研究,2012,21:334-336.
[43] Higuchi ML, Gois JM, Reis MM,et al. Co-infection ra-tios versus inflammation,growth factors and progression of
early atheromas [J]. APMIS, 2006,114(5):338-344.
[44] 张会敏,马宏.肺炎支原体致病机制的研究进展[J].中国现代医
生,2015,53(19):157-160.